• 1. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Comprehensive Overview of (S)-2-Acetamido-N-methyl-3-phenylpropanamide (CAS No. 17186-60-6)

(S)-2-Acetamido-N-methyl-3-phenylpropanamide, identified by its CAS number 17186-60-6, is a chiral organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as a phenylpropanamide derivative, is characterized by its unique stereochemistry and functional groups, making it a valuable intermediate in the synthesis of bioactive molecules. The (S)-enantiomer configuration is particularly noteworthy due to its potential interactions with biological targets, which are often stereospecific.

The molecular structure of (S)-2-Acetamido-N-methyl-3-phenylpropanamide includes an acetamido group, a methylamino moiety, and a phenyl ring, which collectively contribute to its physicochemical properties. These properties include moderate solubility in polar organic solvents and a melting point range that makes it suitable for various synthetic applications. Researchers are increasingly interested in this compound due to its potential role in developing enzyme inhibitors and receptor modulators, particularly in the context of neurological and metabolic disorders.

In recent years, the demand for chiral building blocks like (S)-2-Acetamido-N-methyl-3-phenylpropanamide has surged, driven by the growing emphasis on enantioselective synthesis in drug discovery. This trend aligns with the broader pharmaceutical industry's focus on precision medicine and targeted therapies. The compound's versatility is further highlighted by its use in peptide mimetics and small-molecule probes, which are essential tools for studying protein-ligand interactions.

From a synthetic chemistry perspective, CAS 17186-60-6 can be prepared through multi-step organic reactions, including amide coupling and stereoselective reduction. The purity and enantiomeric excess of the final product are critical parameters, often assessed using techniques such as HPLC and chiral chromatography. These quality control measures ensure that the compound meets the stringent requirements of pharmaceutical applications.

The commercial availability of (S)-2-Acetamido-N-methyl-3-phenylpropanamide has also expanded, with several specialty chemical suppliers offering it as a research-grade reagent. This accessibility has facilitated its adoption in academic and industrial laboratories worldwide. Additionally, the compound's stability under standard storage conditions (e.g., room temperature, inert atmosphere) makes it a practical choice for long-term research projects.

Beyond its immediate applications, (S)-2-Acetamido-N-methyl-3-phenylpropanamide is part of a broader class of N-methylated amides, which are being explored for their bioactivity and drug-like properties. For instance, similar compounds have shown promise as neuroprotective agents and anti-inflammatory compounds, sparking interest in further structure-activity relationship (SAR) studies. The integration of computational chemistry and machine learning in drug design has also opened new avenues for optimizing such molecules.

In summary, (S)-2-Acetamido-N-methyl-3-phenylpropanamide (CAS No. 17186-60-6) represents a versatile and valuable compound in modern chemical research. Its unique structural features, combined with its potential therapeutic applications, make it a subject of ongoing investigation. As the scientific community continues to explore chiral chemistry and drug development, this compound is likely to remain a key player in advancing our understanding of molecular interactions and biological pathways.

• 10125-07-2(Cyclo(-Gly-Phe))
• 147664-63-9(L-Lysinamide,glycyl-L-isoleucylglycyl-L-lysyl-L-phenylalanyl-L-leucyl-L-lysyl-L-lysyl-L-alanyl-L-lysyl-L-lysyl-L-phenylalanylglycyl-L-lysyl-L-alanyl-L-phenylalanyl-L-valyl-L-lysyl-L-isoleucyl-L-leucyl-L-lysyl-)
• 144836-90-8((R)-2-Amino-N-methyl-3-phenylpropanamide)
• 13467-26-0(acetic acid; 2-[(2-aminoacetyl)amino]-3-phenyl-propanamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)